Stryker Neurovascular
Clinical trials sponsored by Stryker Neurovascular, explained in plain language.
A subsidiary of Stryker, focused on neurovascular medical devices.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Mesh tube could seal dangerous brain aneurysms without surgery
Disease control OngoingThis study tests a device called the Surpass Evolve Flow Diverter, a small mesh tube placed inside an artery to redirect blood flow away from a brain aneurysm. The goal is to safely close the aneurysm and prevent it from rupturing. About 248 adults with unruptured, wide-neck aneu…
Phase: NA • Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New brain aneurysm device tracked for 5 years in 500 patients
Disease control OngoingThis study follows 500 people who received the Surpass Evolve flow diverter, a device placed in brain arteries to treat aneurysms. Researchers will track safety and effectiveness for up to 5 years, focusing on stroke risk and aneurysm closure. The goal is to confirm the device wo…
Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New coil device aims to seal brain aneurysms without surgery
Disease control OngoingThis study is testing a new device called the Citadel Embolization Device, a coil used to block blood flow in brain aneurysms. It involves 150 adults aged 18-80 with unruptured or recently ruptured wide-neck aneurysms. The goal is to see if the device safely and effectively seals…
Phase: NA • Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC